The HBSAg Card test is highly accurate in detecting Hepatitis B surface antigen in the blood.

Yes, patient confidentiality is strictly maintained during HBSAg testing, and results are handled discreetly by trained healthcare professionals.

No, additional tests may be required to differentiate between acute (recently acquired) and chronic (long-term) Hepatitis B infection.

The test can detect Hepatitis B surface antigen early in the course of infection, typically within a few weeks after exposure.

A positive result requires further confirmation with additional tests. Counseling and appropriate medical care will be provided to manage Hepatitis B infection effectively.

CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.

CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.

CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.

Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.

CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.

Initially, a light diet is recommended. Gradually, you can return to your regular diet as your digestive system adjusts.